Banquisio, Rhianna S.
HRN: 22-75-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2023
CEFUROXIME 750MG (VIAL)
03/17/2023
03/24/2023
INTRAVENOUS
300 Mg
Q8h
Burns
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes